BRIEF-VTV Therapeutics Announces Reinitiation Of Screening In CATT1 Phase 3 Trial

Reuters
16 May
BRIEF-VTV <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Announces Reinitiation Of Screening In CATT1 Phase 3 Trial

May 15 (Reuters) - vTv Therapeutics Inc VTVT.O:

  • VTV THERAPEUTICS ANNOUNCES REINITIATION OF SCREENING IN CATT1 PHASE 3 TRIAL EVALUATING POTENTIAL FIRST-IN-CLASS LIVER-SELECTIVE GLUCOKINASE ACTIVATOR CADISEGLIATIN FOR TYPE 1 DIABETES

  • VTV THERAPEUTICS INC - TOPLINE CATT1 PHASE 3 DATA EXPECTED IN 2H 2026

  • VTV THERAPEUTICS INC - PROTOCOL AMENDMENT SHORTENS TRIAL DURATION TO 6 MONTHS

Source text: ID:nGNX9tShQd

Further company coverage: VTVT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10